Meilleure Health International Industry Group Limited on 3 July 2026 granted 5.33 million treasury shares to three employees pursuant to its 2026 Share Award Scheme. The allotment represents about 0.13% of the company’s issued share capital.

The awards are made at nil consideration and will vest after a one-year period. Based on the HK$0.249 closing price on the grant date, the notional market value of the shares awarded totals roughly HK$1.33 million.

No performance targets or additional claw-back provisions apply beyond the existing terms of the 2026 Share Award Scheme. The board’s remuneration committee stated that share price performance alone sufficiently aligns employee and shareholder interests.

Following this grant, 403.51 million shares remain available for future awards under the 2026 Share Award Scheme, which has an overall limit of 408.84 million shares.